Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoprolol in Acute Respiratory Distress Syndrome (MAIDEN)
2024-515813-17-00Phase 3Completed
- Sponsor
- Centro de Investigación Biomédica en Red
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute respiratory distress syndrome (ARDS) comparing Beloken (intravenous metoprolol) with Placebo (2 arms). Primary endpoint: Alive and ventilator-free days at 28 days. Started Nov 2024; status: completed.
02
Drugs
metoprolol
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on 2024-515813-17-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515813-17-00.